Clinical trial of sustained-release bezafibrate in patients with severe hypertriglyceridaemia in the US
Latest Information Update: 10 Dec 2013
At a glance
- Drugs Bezafibrate (Primary)
- Indications Hypertriglyceridaemia
- Focus Registrational; Therapeutic Use
- 10 Dec 2013 New trial record
- 11 Nov 2013 An IND was submitted to the US FDA on 27 September 2013 and cleared by the FDA in November 2013, according to a Tribute Pharmaceuticals Canada Inc media release.